Market Place
Sourcing Support
Ascletis Announces Positive Data from Phase IIb Expansion Cohort of ASC22
28 Sep 2023 //
PR NEWSWIRE
Clinical Results of ASC22 in Combination with Chidamide Presented at 12th IAS
24 Jul 2023 //
PR NEWSWIRE
TRACON Pharma Announces Positive Results Based on Ongoing Double-Digit Objective
20 Jun 2023 //
GLOBENEWSWIRE
Ascletis Announces Dosing of the First Patient in the Phase IIb of ASC22
27 Sep 2022 //
PRNEWSWIRE
Biocytogen and Tracon get FDA IND clearance for Phase I/II sarcoma trial
30 Aug 2022 //
CLINICALTRIALSARENA
US FDA Approval of IND for CTLA-4 Antibody YH001
29 Aug 2022 //
BUSINESSWIRE
Ascletis Begins Dosing in PII Trial of ASC22 for HIV-1 Infection
28 Jun 2022 //
PRNEWSWIRE
Ascletis` Subcutaneous PD-L1 Antibody ASC22 for Chronic Hepatitis B
26 Jun 2022 //
PRNEWSWIRE
Ascletis Announces U.S. IND Approval of ASC22 in HIV
11 May 2022 //
ASIAONE
SPHCC Initiated Study of Envafolimab + Chidamide in HIV
14 Feb 2022 //
PRNEWSWIRE
FDA Approves Ascletis` IND Approval of ASC61 for Advanced Solid Tumors
06 Feb 2022 //
PRNEWSWIRE
Ascletis Announces U.S. IND Approval of ASC22 for Chronic Hepatitis B
17 Jan 2022 //
PRNEWSWIRE
TRACON Announces Positive Results from IDMC Review from Ongoing ENVASARC Trial
27 Dec 2021 //
GLOBENEWSWIRE
Clinical Study of ASC22 for HBV Functional Cure Selected by AASLD
15 Nov 2021 //
PRNEWSWIRE
NMPA Approves Ascletis` ASC22 for HIV-1 Infected Patients
09 Nov 2021 //
PRNEWSWIRE
Ascletis Shows Interim Results of Phase IIb Study of ASC22
08 Nov 2021 //
PRNEWSWIRE
Ascletis, Suzhou Alphamab Expand their Partnership Worldwide for ASC22
07 Nov 2021 //
PRNEWSWIRE
Ascletis Announces Results of the Phase IIa trial of ASC22 Envafolimab
12 Oct 2021 //
PRNEWSWIRE
TRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab
29 Jun 2021 //
GLOBENEWSWIRE
TRACON Announces Acceptance of the Envafolimab (KN035) NDA
19 Jan 2021 //
GLOBENEWSWIRE
TRACON Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA
30 Dec 2020 //
GLOBENEWSWIRE
TRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results
21 Sep 2020 //
GLOBENEWSWIRE
Ascletis Pharma begins patients dosing in phase IIa trial of Envafolimab
17 Aug 2020 //
PHARMABIZ
TRACON Announces Successful Type B Meeting with FDA for Envafolimab
11 May 2020 //
GLOBENEWSWIRE
Alphamab Oncology loads up $100M-plus from marquee backers
20 Nov 2018 //
ENDPTS
Alphamab starts phase I clinical trial in Australia
11 Oct 2018 //
BIOSPECTRUM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.